The Role of Chitosan Oligosaccharide in Metabolic Syndrome: A Review of Possible Mechanisms
Metabolic syndrome, a cluster of metabolic disorders including central obesity, insulin resistance, hyperglycemia, dyslipidemia, and hypertension, has become a major public health problem worldwide. It is of great significance to develop natural products to prevent and treat metabolic syndrome. Chit...
Main Authors: | Wenjing Tao, Geng Wang, Jintao Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/19/9/501 |
Similar Items
-
Chitosan Oligosaccharide Alleviates Abnormal Glucose Metabolism without Inhibition of Hepatic Lipid Accumulation in a High-Fat Diet/Streptozotocin-Induced Diabetic Rat Model
by: Shing-Hwa Liu, et al.
Published: (2021-06-01) -
Chitosan Oligosaccharide Ameliorates Metabolic Syndrome Induced by Overnutrition via Altering Intestinal Microbiota
by: Yihua Wang, et al.
Published: (2021-10-01) -
Intestinal Population in Host with Metabolic Syndrome during Administration of Chitosan and Its Derivatives
by: Chen Yan, et al.
Published: (2020-12-01) -
Chitin Oligosaccharide and Chitosan Oligosaccharide: Two Similar but Different Plant Elicitor
by: Heng eYin, et al.
Published: (2016-04-01) -
Effects of Chitosan Oligosaccharide on Plasma and Hepatic Lipid Metabolism and Liver Histomorphology in Normal Sprague-Dawley Rats
by: Shing-Hwa Liu, et al.
Published: (2020-08-01)